Literature DB >> 7027555

Recurrence of focal segmental glomerulosclerosis in renal allografts.

J Pinto, G Lacerda, J S Cameron, D R Turner, M Bewick, C S Ogg.   

Abstract

Thirty-one renal allografts placed in 25 recipients with renal failure from biopsy-documented focal segmental glomerulosclerosis (FSGS) were reviewed. These represent all of the cases with this renal histology transplanted over 13 years. Recurrence of the lesion was demonstrated histologically in five recipients. A nephrotic syndrome occurred in all five patients and failure of the graft in two. Of 20 recipients who did not show a nephrotic syndrome, allograft histology in 12 did not show FSGS in any. From these data and a review of the literature, the risks of transplantation in patients with FSGS are assessed. Recipients under the age of 15 and with a course into renal failure of less than 3 years show recurrence in about 50% of cases. Of this 50%, about one-half will lose their grafts from the recurrence within 5 years, but some may show good function for many years, despite proteinuria or a nephrotic syndrome.

Entities:  

Mesh:

Year:  1981        PMID: 7027555     DOI: 10.1097/00007890-198108000-00001

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  16 in total

1.  Rituximab and Therapeutic Plasma Exchange in Recurrent Focal Segmental Glomerulosclerosis Postkidney Transplantation.

Authors:  Sami Alasfar; Dany Matar; Robert A Montgomery; Niraj Desai; Bonnie Lonze; Vikas Vujjini; Michelle M Estrella; John Manllo Dieck; Gebran Khneizer; Sanja Sever; Jochen Reiser; Nada Alachkar
Journal:  Transplantation       Date:  2018-03       Impact factor: 4.939

2.  Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation.

Authors:  Therese C Jungraithmayr; Katrin Hofer; Pierre Cochat; Gil Chernin; Gerard Cortina; Sonja Fargue; Paul Grimm; Tanja Knueppel; Andreas Kowarsch; Thomas Neuhaus; Philipp Pagel; Karl P Pfeiffer; Franz Schäfer; Ulf Schönermarck; Tomas Seeman; Burkhard Toenshoff; Stefanie Weber; Michelle P Winn; Johannes Zschocke; Lothar B Zimmerhackl
Journal:  J Am Soc Nephrol       Date:  2011-02-25       Impact factor: 10.121

3.  Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect?

Authors:  B H Markus; R J Duquesnoy; R D Gordon; J J Fung; M Vanek; G Klintmalm; C Bryan; D Van Thiel; T E Starzl
Journal:  Transplantation       Date:  1988-09       Impact factor: 4.939

4.  Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts.

Authors:  P Senggutuvan; J S Cameron; R B Hartley; S Rigden; C Chantler; G Haycock; D G Williams; C Ogg; G Koffman
Journal:  Pediatr Nephrol       Date:  1990-01       Impact factor: 3.714

5.  Early use of plasmapheresis for recurrent post-transplant FSGS.

Authors:  Madhura Pradhan; Julie Petro; Joanne Palmer; Kevin Meyers; H Jorge Baluarte
Journal:  Pediatr Nephrol       Date:  2003-06-26       Impact factor: 3.714

Review 6.  [Recurrence of the original disease in the transplanted kidney].

Authors:  E P Leumann; J Briner
Journal:  Klin Wochenschr       Date:  1984-04-02

7.  Recurrent nephrotic syndrome after transplantation: early treatment with plasmaphaeresis and cyclophosphamide.

Authors:  P Cochat; A Kassir; S Colon; C Glastre; B Tourniaire; B Parchoux; X Martin; L David
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

8.  A transplant of real life.

Authors:  V Diaz
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

9.  Focal and segmental glomerulosclerosis induced in mice lacking decay-accelerating factor in T cells.

Authors:  Lihua Bao; Mark Haas; Jeffrey Pippin; Ying Wang; Takashi Miwa; Anthony Chang; Andrew W Minto; Miglena Petkova; Guilin Qiao; Wen-Chao Song; Charles E Alpers; Jian Zhang; Stuart J Shankland; Richard J Quigg
Journal:  J Clin Invest       Date:  2009-05       Impact factor: 14.808

Review 10.  Focal segmental glomerulosclerosis.

Authors:  I Ichikawa; A Fogo
Journal:  Pediatr Nephrol       Date:  1996-06       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.